Director, US GI Analytics
Revolution Medicines
Summary
Reporting to the Senior Director, GI Analytics & Insights, the Director, GI Analytics will serve as the analytics lead for Revolution Medicines’ GI cancer portfolio.
Job description
This role will partner closely with Commercial, Medical Affairs, Market Access, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance.
The role requires a strong understanding of the PDAC and CRC cancer treatment landscape, patient journey, biomarker-driven markets, and oncology data assets.
This position is based at our Redwood City, CA headquarters, with flexibility for remote candidates willing to travel regularly to the office.
Responsibilities include:
- Lead analytics strategy and execution for Revolution Medicines’ GI cancer portfolio.
- Partner with cross-functional stakeholders to identify key business questions and translate them into analytical plans and actionable recommendations.
- Generate insights from patient-, physician-, claims-, EMR-, and market-level data to inform portfolio strategy, launch planning, and commercial decision-making.
- Develop analyses to understand patient identification, biomarker testing patterns, treatment sequencing, referral pathways, and barriers to adoption.
- Conduct market opportunity assessments, patient journey analyses, and competitive landscape evaluations to support strategic planning.
- Design and execute segmentation, targeting, and opportunity identification analyses to inform customer engagement strategies.
- Monitor evolving standards of care, treatment dynamics, and competitor activity across GI cancer indications.
- Partner with Forecasting, Market Research, and Competitive Intelligence colleagues to develop an integrated view of market performance and future growth opportunities.
- Lead development of key performance metrics, dashboards, and launch readiness assessments.
- Inform data acquisition and data strategy decisions to ensure availability of fit-for-purpose oncology data assets.
- Manage external analytics vendors and ensure timely delivery of high-quality analyses.
- Communicate insights and strategic implications to senior leadership through clear, concise, and compelling recommendations.
- Represent Revolution Medicines’ values in all internal and external interactions.
Required Skills, Experience and Education:
- Bachelor’s degree required; advanced degree preferred.
- 8+ years of experience in pharmaceutical, biotechnology, healthcare analytics, or management consulting.
- Oncology analytics experience required; GI cancer (PDAC and/or CRC) experience strongly preferred.
- Demonstrated expertise working with healthcare claims, EMR, specialty pharmacy, and other patient-level datasets.
- Experience supporting oncology product launches and pre-launch planning.
- Strong analytical, problem-solving, and strategic thinking skills.
- Proven ability to influence cross-functional teams and senior leadership.
- Excellent communication and presentation skills.
- Ability to thrive in a fast-paced, entrepreneurial environment.
Preferred Skills:
- MBA, MPH, MS, or PhD.
- Deep understanding of PDAC and/or CRC and biomarker-driven oncology markets.
- Experience supporting targeted oncology therapies.
- Experience with advanced analytics, predictive modeling, AI/ML applications, or commercial forecasting.
- Prior experience in a growth-stage biotechnology company.
Requirements
- Bachelor’s degree required; advanced degree preferred.
- 8+ years of experience in pharmaceutical, biotechnology, healthcare analytics, or management consulting.
- Oncology analytics experience required; GI cancer (PDAC and/or CRC) experience strongly preferred.
- Demonstrated expertise working with healthcare claims, EMR, specialty pharmacy, and other patient-level datasets.
- Experience supporting oncology product launches and pre-launch planning.
- Strong analytical, problem-solving, and strategic thinking skills.
- Proven ability to influence cross-functional teams and senior leadership.
- Excellent communication and presentation skills.
- Ability to thrive in a fast-paced, entrepreneurial environment.
- MBA, MPH, MS, or PhD.
- Deep understanding of PDAC and/or CRC and biomarker-driven oncology markets.
- Experience supporting targeted oncology therapies.
- Experience with advanced analytics, predictive modeling, AI/ML applications, or commercial forecasting.
- Prior experience in a growth-stage biotechnology company.
Benefits
- Competitive cash compensation
- Equity awards
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.